CD44-deficient mice develop normally with changes in subpopulations and recirculation of lymphocyte subsets

Journal of Immunology

Volumn 163, Issue 9, 1999, Pages 4917-4923

  Protin, Ursula ^a   Schweighoffer, Tamas ^b   Jochum, Wolfram ^c   Hilberg, Frank ^b  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^b BOEHRINGER INGELHEIM RCV GMBH AND CO KG   (Austria)

^c RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; EMBRYO PATTERN FORMATION; GENE TARGETING; LYMPHOCYTE RECIRCULATION; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTE TRANSFER; LYMPHOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; THYMUS;

ANIMALS; ANTIGENS, CD44; CELL DIFFERENTIATION; CELL MOVEMENT; EMBRYONIC AND FETAL DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE TARGETING; LYMPHOCYTE SUBSETS; LYMPHOID TISSUE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; THYMUS GLAND;

EID: 0032736501     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Adams, J. C., and F. M. Watt. 1993. Regulation of development and differentiation by the extracellular matrix. Development 117:1183.
2. Lin, C. Q., and M. L. Bissell. 1993. Multi-faceted regulation of cell differentiation by extracellular matrix. FASEB J. 7:737.
3. Springer, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301.
4. Ponta, H., J. Sleeman, P. Dall, J. Moll, L. Sherman, and P. Herrlich. 1994. CD44 isoforms in metastatic cancer. Invasion Metastasis 14:82.
5. Herrlich, P., S. Pals, and H. Ponta. 1995. CD44 in colon cancer. Eur. J. Cancer 31:1110.
6. Yu, Q. and B. P. Toole. 1996. A new alternatively spliced exon between v9 and v10 provides a molecular basis for synthesis of soluble CD44. J. Biol. Chem. 271:20603.
7. Screaton G. R., M. V. Bell, J. I. Bell, and D. G. Jackson. 1993. The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor: comparison of all 10 variable exons between mouse, human and rat. J. Biol. Chem. 268:12235.
8. Toelg, C., M. Hofmann, P. Herrlich, and H. Ponta. 1993. Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res. 21:1225.
9. Jalkanen, S., and M. Jalkanen. 1992. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J. Cell Biol. 116:817.
10. Bennett, K., D. G. Jackson, J. C. Simon, E. Tanczos, R. Peach, B. Modrell, I. Stamenkovic, G. Plowman, and A. Aruffo. 1995. CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J. Cell Biol. 128:687.
11. Weber, G. F., S. Ashkar, M. J. Glimcher, and H. Cantor. 1996. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271:509.
12. Naujokas, M. F., M. Morin, M. S. Anderson, M. Peterson, and J. Miller. 1993. The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44. Cell 74:257.
13. Aruffo, A., I. Stamenkovic, M. Melnick, C. B. Underhill, and B. Seed. 1990. CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303.
14. Miyake, K., C. B. Underhill, J. Lesley, and P. W. Kincade. 1990. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J. Exp. Med. 172:69.
15. Peach, R. J., D. Hollenbaugh, I. Stamenkovic, and A. Aruffo. 1993. Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J. Cell Biol. 122:257.
16. Yang, B., B. L. Yang, R. C. Savani, and E. A. Turley 1994. Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. EMBO J. 13:286.
17. Took, B. P., S. I. Munaim, S. Welles, and C. B. Knudson. 1989. Hyaluronate-cell interactions and growth factor regulation of hyaluronate synthesis during limb development. Ciba Found. Symp. 143:138.
18. Culty, M., H. A. Nguyen, and C. B. Underhill. 1992. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J. Cell Biol. 116:1055.
19. Guenthert, U., M. Hofmann, W. Rudy, S. Reber, M. Zöller, I. Haussmann, S. Matzku, A. Wenzel, H. Ponta, and P. Herrlich. 1991. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13.
20. Guenthert, U. 1993. CD44: a multitude of isoforms with diverse functions. Curr. Top. Microbiol. Immunol. 184:47.
21. Pals, S. T., O. Koopman, A. Griffioen, H. Ponta, P. Herrlich, F. van den Berg, and E. Horst. 1993. CD44: a variety of isoforms with functions in cell adhesion and tumor metastasis. In Lymphocyte Adhesion Molecules. Y. Shimizu, ed. R.G. Landes, Austin, TX, p. 135.
22. Lesley, J., R. Hyman, and P. W. Kincade. 1993. CD44 and its interactions with the extracellular matrix. Adv. Immunol. 54:271.
23. Seiter, S., R. Arch, S. Reber, D. Komotowski, M. Hofmann, H. Ponta, P. Herrlich, S. Matzku, and M. Zoller. 1993. Prevention of tumor metastasis formation by anti-variant CD44. J. Exp. Med. 177:443.
24. Mackay, C. R., H. J. Terpe, R. Stauder, W. L. Marston, H. Stark, and U. Guenthert. 1994. Expression and modulation of CD44 variant isoforms in humans. J. Cell Biol. 124:71.
25. Kincade, P. W. 1993. Cell adhesion mechanisms utilized for lympho-hematopoiesis. In Lymphocyte Adhesion Molecules. Y. Shimizu, ed. R.G. Landes, Austin, TX, p. 249.
26. O'Neill, H. C. 1989. Antibody which defines a subset of bone marrow cells that can migrate to the thymus. Immunology 68:59.
27. Horst, E., C. J. Meijer, A. M. Duijvestijn, N. Hartwig, H. J. Van der Harten, and S. T. Pals. 1990. The ontogeny of human lymphocyte recirculation: high endothelial cell antigen (HECA-452) and CD44 homing receptor expression in the development of the immune system. Eur. J. Immunol. 20:1483.
28. Mareel, M. M., F. M. Van Roy, and P. De Baetselier. 1990. The invasive phenotypes. Cancer Metastasis Rev. 9:45.
29. Rudy, W., M. Hofmann, R. Schwartz-Albiez, M. Zöller, K.-H. Heider, H. Ponta, and P. Herrlich. 1993. The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. Cancer Res. 53:1262.
30. Arch, R., K. Wirth, M. Hofmann, H. Ponta, S. Matzku, P. Herrlich, and M. Zöller. 1992. Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 257:682.
31. Ruiz, P., C. Schwärzler, and U. Guenthert. (1995). CD44 isoforms during differentiation and development. Biol. Essays 17:17.
32. Kennell, S. J., T. K. Lankford, L. J. Foote, S. G. Shinpock, and C. Stringer. 1993. CD44 expression on murine tissues. J. Cell Sci. 104:373.
33. Wheatley, S. C., C. M. Isacke, and P. H. Crossley. 1993. Restricted expression of the hyaluronan receptor, CD44, during postimplantation mouse embryogenesis suggests key roles in tissue formation and patterning. Development 119:295.
34. Yu, Q., N. Grammatikakis, and B. P. Toole. 1996. Expression of multiple CD44 isoforms in the apical ectodermal ridge of the embryonic mouse limb. Dev. Dyn. 207:204.
35. Sherman, L., D. Wainwright, H. Ponta, and P. Herrlich. 1998. A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb outgrowth. Genes Dev. 12:1058.
36. Thomas, K. R., and M. R. Capecchi. 1990. Targeted disruption of the murine int-1 proto-oncogene resulting in severe abnormalities in midbrain and cerebellar development. Nature 346:847.
37. Le Mouellic, H., Y. Lallemand, and P. Brulet. 1990. Targeted replacement of the homeobox gene Hox-3.1 by the Escherichia coli lacZ in mouse chimeric embryos. Proc. Natl. Acad. Sci. USA 87:4712.
38. Nagy, A., J. Rossant, R. Nagy, W. Abramow-Newerly, and J. Roder. 1993. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl. Acad. Sci. USA 90:8424.
39. Hilberg, F., A. Aguzzi, N. Howells, and E. F. Wagner. 1993. c-jun is essential for normal mouse development and hepatogenesis. Nature 365:179.
40. Hilberg, F., and E. F. Wagner. 1992. Embryonic stem (ES) cells lacking functional c-jun: consequences for growth and differentiation, AP-1 activity and tumorigenicity. Oncogene 7:2371.
41. Arbones, M. L., D. C. Ord, K. Ley, H. Ratech, C. Maynard-Curry, G. Otten, D. J. Capon, and T. F. Tedder. 1994. Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. Immunity 1:247.
42. Kaya, G., I. Rodriguez, J. L. Jorcano, P. Vassalli, and I. Stamenkovic. 1997. Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation. Genes Dev. 11:996.
43. Koopman, G., K.-H. Heider, E. Horst, G. R. Adolf, F. van den Berg, P. Herrlich, and S. T. Pals. 1993. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J. Exp. Med. 177:897.
44. Shtivelman, E. and J. M. Bishop. 1991. Expression of CD44 is repressed in neuroblastoma cells. Mol. Cell. Biol. 11:5446.
45. Bernard, J. 1995. Genetic alterations associated with metastatic dissemination and chemoresistance in neuroblastoma. Eur. J. Cancer 31:560.
46. Takahashi, K., I. Stamenkovic, M. Cutler, H. Saya, and K. K. Tanabe. 1995. CD44 hyaluronate binding influences growth kinetics and tumorigenicity of human colon carcinomas. Oncogene 11:2223.
47. Lenardo, M. J. 1991. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 353:858.
48. Willerford, D., J. Chen, J. Ferry, L. Davidson, A. Ma, and F. W. Alt. 1995. Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3:521.
49. Horst, E., C. J. Meijer, T. Radaszkiewicz, G. J. Ossekoppele, J. H. Van Krieken, and S. T. Pals. 1990. Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/18), and ICAM-1 (CD54). Leukemia 4:595.
50. Hamann, A., D. Jablonski-Westrich, A. Duijvestijn, E. C. Butcher, H. Baisch, R. Harder, and H. G. Thiele. 1988. Evidence for an accessory role of LFA-1 in lymphocyte-high endothelium interaction during homing. J Immunol. 140:693.
51. Koopman, G., van Kooyk, Y., de Graaff, M., Meyer, C. J ., Figdor, C. G. and Pals, S. T. 1990. Triggering of the CD44 antigen on T lymphocytes promotes T cell adhesion through the LFA-1 pathway. J. Immunol. 145:3589.
52. Dillon, P. W., K. Keefer, J. Blackburn, P. E. Houghton, and T. M. Krummel. 1994. The extracellular matrix of the fetal wound: hyaluronic acid controls lymphocyte adhesion. J. Surg. Res. 57:170.
53. 1 and the CD44 adhesion receptor. Blood 15:1802.
54. Brissett, N. C., and S. J. Perkins. 1996. The protein fold of the hyaluronate-binding proteoglycan tandem repeat domain of link protein, aggrecan and CD44 is similar to that of the C-type lectin superfamily. FEBS Lett. 388:211.